References
- 1. Kooij SJ, Bejerot S, Blackwell A et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010; 10:67.
- 2. Stein MA. Impairment associated with adult ADHD. CNS Spectr 2008; 13 (12) :9-1.
- 3. Arnsten AF, Li BM. Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions. Biological Psychiatry 2005; 57 (11): 1377-84.
- 4. Bolden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52 (12): 1023-9.
- 5.Grizenko N, Bhat M, Schwartz G, Ter-Stepanian M,Joober R.Efficacyofmethylphenidate in childrenwithat ten - tion-deficithyperactivitydisorder and learningdisabilities: a randomizedcrossover trial. J PsychiatryNeurosci. 2006; 31(1): 46-51.
- 6. Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer TJ, Biederman J, Wernicke J, Newcorn JH, Casat C, Milton D, Michelson D. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 2002; 41(7): 776-84.
- 7. Yildiz O, Sismanlar SG, Memik NC, Karakaya I, AgaogluB.Atomoxetine and Methylphenidate Treatment in Children with ADHD: The Efficacy, Tolerability and Effects on Executive Functions. Child Psychiatry & Human Development 2011; 42 (3): 257-269.
- 8. Garg J, Arun P, ChavanBS. Comparativeshort term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder. Indian Pediatr. 2014; 51: 550-554.
- 9. Lv XZ, Shu Z, Zhang YW, Wu SS, Zhan SY. Effectiveness and safety of methylphenidate and atomoxetine for attention deficit hyperactivity disorder: a systematic review. Transl Pediatr 2012; 1: 47-53.
- 10. Gibdon AP, Bettinger TL, Patel NC, Crismon ML. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann Pharmacother 2006; 40 (6) :1134-42.
- 11. Hanwella R, Senanayake M, Silva V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a metaanalysis. BMC Psychiatry 2011; 11: 168-176.
- 12. Ghuman JK, Breitborde NJK.Review: methylphenidate and atomoxetine have similar efficacy and acceptability in children and adolescents with ADHD Evid Based Mental Health 2012; 15: 68-74.
- 13. Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 2008; 165 (6):721-30.